{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:37Z","timestamp":1781513737800,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.humimm.2025.111633","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T08:17:31Z","timestamp":1765786651000},"page":"111633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq files"],"prefix":"10.1016","volume":"87","author":[{"given":"Madeline C.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8819-7167","authenticated-orcid":false,"given":"Srijit","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3757-167X","authenticated-orcid":false,"given":"Genesis V.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2334-6188","authenticated-orcid":false,"given":"Nandini","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-7078","authenticated-orcid":false,"given":"Taha I.","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4000-372X","authenticated-orcid":false,"given":"Tushar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1664-0996","authenticated-orcid":false,"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2025.111633_b0005","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. Epub 20240404. doi: 10.3322\/caac.21834. PubMed PMID: 38572751.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.humimm.2025.111633_b0010","doi-asserted-by":"crossref","unstructured":"Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, Siegel RL, Anderson RN, Kohler BA, Benard VB, Negoita S, Wiggins C, Cance WG, Jemal A. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. 2022;128(24):4251-84. Epub 20221027. doi: 10.1002\/cncr.34479. PubMed PMID: 36301149; PubMed Central PMCID: PMCPMC10092838.","DOI":"10.1002\/cncr.34479"},{"key":"10.1016\/j.humimm.2025.111633_b0015","doi-asserted-by":"crossref","unstructured":"Hernandez-Blanquisett A, Quintero-Carreno V, Martinez-Avila MC, Porto M, Manzur-Barbur MC, Buendia E. Metastatic Pancreatic Cancer: Where Are We? Oncol Rev. 2023;17:11364. Epub 20240118. doi: 10.3389\/or.2023.11364. PubMed PMID: 38304752; PubMed Central PMCID: PMCPMC10830814.","DOI":"10.3389\/or.2023.11364"},{"key":"10.1016\/j.humimm.2025.111633_b0020","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.humimm.2025.111633_b0025","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol."},{"key":"10.1016\/j.humimm.2025.111633_b0030","unstructured":"Fiorino S, Cuppini A, Castellani G, Bacchi-Reggiani ML, Jovine E. HBV- and HCV-related infections and risk of pancreatic cancer. JOP. 2013;14(6):603-9. Epub 20131110. doi: 10.6092\/1590-8577\/1948. PubMed PMID: 24216545."},{"issue":"1","key":"10.1016\/j.humimm.2025.111633_b0035","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70046","article-title":"Better Outcomes for Ovarian Cancer Associated with the Detection of Anti-EBV TCR CDR3s: potential Relevance to Diffuse Large B-Cell Lymphoma","volume":"93","author":"Goel","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2025.111633_b0040","doi-asserted-by":"crossref","unstructured":"Jain R, Huda TI, Paul S, Chobrutskiy A, Chobrutskiy BI, Baker MC, Goel N, Blanck G. Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphoma. International journal of cancer Journal international du cancer. 2025;156(3):652-Epub 2024100doi: 10.1002\/ijc.35212. PubMed PMID: 39377612.","DOI":"10.1002\/ijc.35212"},{"key":"10.1016\/j.humimm.2025.111633_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CIN.S35784","article-title":"Detection of Productively Rearranged TcR-alpha V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells","volume":"15","author":"Gill","year":"2016","journal-title":"Cancer Inform."},{"issue":"3","key":"10.1016\/j.humimm.2025.111633_b0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11060-018-03001-1","article-title":"Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade","volume":"140","author":"Chobrutskiy","year":"2018","journal-title":"J. Neurooncol"},{"issue":"3","key":"10.1016\/j.humimm.2025.111633_b0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/21645515.2016.1246095","article-title":"Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer","volume":"13","author":"Tong","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.humimm.2025.111633_b0060","doi-asserted-by":"crossref","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Cancer Genome Atlas Research N, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L. The Immune Landscape of Cancer. Immunity. 2018;48(4):812-30 e14. doi: 10.1016\/j.immuni.2018.03.023. PubMed PMID: 29628290; PubMed Central PMCID: PMCPMC5982584.","DOI":"10.1016\/j.immuni.2018.03.023"},{"issue":"9","key":"10.1016\/j.humimm.2025.111633_b0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","article-title":"VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2","volume":"19","author":"Goncharov","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.humimm.2025.111633_b0070","doi-asserted-by":"crossref","unstructured":"Herbein G. High-Risk Oncogenic Human Cytomegalovirus. Viruses. 2022;14(11). Epub 20221107. doi: 10.3390\/v14112462. PubMed PMID: 36366560; PubMed Central PMCID: PMCPMC9695668.","DOI":"10.3390\/v14112462"},{"key":"10.1016\/j.humimm.2025.111633_b0075","doi-asserted-by":"crossref","unstructured":"El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From \u201cCanonical\u201d Diseases Toward Virus-Elicited Oncomodulation. Frontiers in immunology. 2021;12:730765. Epub 20210908. doi: 10.3389\/fimmu.2021.730765. PubMed PMID: 34566995; PubMed Central PMCID: PMCPMC8456041.","DOI":"10.3389\/fimmu.2021.730765"},{"key":"10.1016\/j.humimm.2025.111633_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-0716-2712-9_13","article-title":"Epitope-specific T Cell Receptor Data and Tools in the Immune Epitope Database","volume":"2574","author":"Chronister","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.humimm.2025.111633_b0085","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling. 2013;6(269):pl1. doi: 10.1126\/scisignal.2004088. PubMed PMID: 23550210; PubMed Central PMCID: PMC4160307.","DOI":"10.1126\/scisignal.2004088"},{"issue":"5","key":"10.1016\/j.humimm.2025.111633_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.humimm.2025.111633_b0095","doi-asserted-by":"crossref","unstructured":"Eakins RA, Chobrutskiy A, Teer JK, Patel DN, Hsiang M, Huda TI, Zaman S, Sexton WJ, Coppola D, Falasiri S, Blanck G, Chobrutskiy BI. Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3\/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity. Molecular immunology. 2022;150:58-66. Epub 20220817. doi: 10.1016\/j.molimm.2022.08.001. PubMed PMID: 35987136.","DOI":"10.1016\/j.molimm.2022.08.001"},{"key":"10.1016\/j.humimm.2025.111633_b0100","doi-asserted-by":"crossref","unstructured":"Marrack P, Krovi SH, Silberman D, White J, Kushnir E, Nakayama M, Crooks J, Danhorn T, Leach S, Anselment R, Scott-Browne J, Gapin L, Kappler J. The somatically generated portion of T cell receptor CDR3alpha contributes to the MHC allele specificity of the T cell receptor. Elife. 2017;6. doi: 10.7554\/eLife.30918. PubMed PMID: 29148973; PubMed Central PMCID: PMCPMC5701794.","DOI":"10.7554\/eLife.30918"},{"key":"10.1016\/j.humimm.2025.111633_b0105","doi-asserted-by":"crossref","unstructured":"Wang J, Wang H, Ding Y, Cao N, Nan F, Wu F, Li C, Liang X, Xiao M, Guo J, Gao Z, Yan L, Zhou T, Li Y, Zhai Z. Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T. J Transl Med. 2025;23(1):171. Epub 20250210. doi: 10.1186\/s12967-025-06188-w. PubMed PMID: 39930509; PubMed Central PMCID: PMCPMC11809011.","DOI":"10.1186\/s12967-025-06188-w"},{"key":"10.1016\/j.humimm.2025.111633_b0110","doi-asserted-by":"crossref","unstructured":"Donzel M, Bonjour M, Combes JD, Broussais F, Sesques P, Traverse-Glehen A, de Martel C. Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France. EClinicalMedicine. 2022;54:101674. Epub 20221001. doi: 10.1016\/j.eclinm.2022.101674. PubMed PMID: 36204003; PubMed Central PMCID: PMCPMC9531037.","DOI":"10.1016\/j.eclinm.2022.101674"},{"key":"10.1016\/j.humimm.2025.111633_b0115","article-title":"Evidence of Epstein-Barr Virus Association with Head and Neck Cancers: a Review","volume":"82","author":"Prabhu","year":"2016","journal-title":"J. Can. Dent. Assoc."},{"key":"10.1016\/j.humimm.2025.111633_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ebiom.2016.05.025","article-title":"Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation","volume":"9","author":"Hu","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humimm.2025.111633_b0125","doi-asserted-by":"crossref","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235. Epub 20230619. doi: 10.1038\/s41392-023-01471-y. PubMed PMID: 37332039; PubMed Central PMCID: PMCPMC10277291.","DOI":"10.1038\/s41392-023-01471-y"},{"issue":"1","key":"10.1016\/j.humimm.2025.111633_b0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.0105-2896.2010.00902.x","article-title":"Granzyme a activates another way to die","volume":"235","author":"Lieberman","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2025.111633_b0135","doi-asserted-by":"crossref","unstructured":"Zheng Z, Guo Y, Huang X, Liu J, Wang R, Qiu X, Liu S. CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer. Cancers. 2022;14(19). Epub 20221005. doi: 10.3390\/cancers14194866. PubMed PMID: 36230788; PubMed Central PMCID: PMCPMC9564077.","DOI":"10.3390\/cancers14194866"},{"key":"10.1016\/j.humimm.2025.111633_b0140","doi-asserted-by":"crossref","unstructured":"Huo Q, Ning L, Xie N. Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis. Breast Cancer (Dove Med Press). 2023;15:213-26. Epub 20230310. doi: 10.2147\/BCTT.S400808. PubMed PMID: 36926265; PubMed Central PMCID: PMCPMC10013577.","DOI":"10.2147\/BCTT.S400808"},{"key":"10.1016\/j.humimm.2025.111633_b0145","doi-asserted-by":"crossref","unstructured":"Kim S, Park BK, Seo JH, Choi J, Choi JW, Lee CK, Chung JB, Park Y, Kim DW. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases. Scientific reports. 2020;10(1):8820. Epub 20200601. doi: 10.1038\/s41598-020-65720-8. PubMed PMID: 32483216; PubMed Central PMCID: PMCPMC7264353.","DOI":"10.1038\/s41598-020-65720-8"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:23:49Z","timestamp":1781511829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0198885925004045"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111633","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq files","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111633"}}